HSTM files Form 144 for 2,000-share sale

HSTM submitted a Form 144 notice for the proposed sale of common stock.

Rhea-AI Filing Summary

HSTM submitted a Form 144 notice for the proposed sale of common stock. The filing lists a proposed sale by Linda Rebrovick of 2,000 shares dated 05/28/2026 with an amount shown as $50,000.00. The excerpt also lists stock awards dated 09/10/2021 (188 shares), 03/24/2014 (1,149 shares) and 04/26/2016 (663 shares), and names UBS Financial Services, Inc. as the broker.

Insights

Securities Compliance Officer

Form 144 reports a proposed brokered resale of common shares by an affiliate.

The filing lists a proposed sale of 2,000 shares by Linda Rebrovick on 05/28/2026 and names UBS Financial Services, Inc. as broker. The excerpt shows related stock awards with dates and share counts.

Timing, sale method, and final proceeds depend on later execution and any applicable transfer restrictions; subsequent filings will show completion if trades occur.

Corporate Secretary

This is an administrative resale notice under Rule 144, not a corporate action.

The document records the seller, broker, dates, and specific award lots (188; 1,149; 663). It functions as a public notice of intent to sell rather than evidence of a completed transaction.

No new corporate financing or governance change is disclosed in the excerpt.

Key Figures

Proposed sale: 2,000 shares Amount shown: $50,000.00 Award lot: 188 shares +4 more

7 metrics

Proposed sale 2,000 shares proposed sale dated 05/28/2026

Amount shown $50,000.00 line item associated with the 2,000-share entry

Award lot 188 shares Stock award dated 09/10/2021

Award lot 1,149 shares Stock award dated 03/24/2014

Award lot 663 shares Stock award dated 04/26/2016

Exchange listed Nasdaq exchange noted in excerpt

Filing reference date 06/01/2026 date appearing in the securities header

Key Terms

Form 144, Stock Award, Broker-dealer

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months Linda Rebrovick ..."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Award financial

"Stock Award | Issuer | 188 | 09/10/2021"

Broker-dealer financial

"UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010"

A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HSTM's Form 144 disclose about the proposed sale?

It discloses a proposed sale by Linda Rebrovick of 2,000 shares dated 05/28/2026. The filing names UBS Financial Services, Inc. as broker and shows an associated dollar figure of $50,000.00 in the excerpt.

Which specific awards or lots are listed in the HSTM excerpt?

The excerpt lists three stock award lots: 09/10/2021 (188 shares), 03/24/2014 (1,149 shares), and 04/26/2016 (663 shares). These dates and counts appear under the "Securities To Be Sold" section.

Does the Form 144 confirm that the shares were sold?

No: the filing is a notice of a proposed sale and reports intent and broker details. Execution and settlement are not confirmed here; completion would typically appear in later trade reports or amendments.

Who is the broker handling the proposed HSTM sale?

The broker named in the excerpt is UBS Financial Services, Inc. with an address at Eleven Madison Avenue, New York. The filing ties the proposed sale to that broker rather than specifying execution details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:25 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001217283
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHSTREAM INC
SEC File Number	000-27701
Address of Issuer	500 11TH AVENUE NORTH SUITE 850 NASHVILLE TENNESSEE 37203
Phone	6153013100
Name of Person for Whose Account the Securities are To Be Sold	REBROVICK LINDA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	2000	50000.00	29356350	06/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2021	Stock Award	Issuer			188	09/10/2021	NA
Common	03/24/2014	Stock Award	Issuer			1149	03/24/2014	NA
Common	04/26/2016	Stock Award	Issuer			663	04/26/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Linda Rebrovick 500 11th Avenue North Suite 850 Nashville TN 37203	Common	05/28/2026	2000	50000.00

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	1s/ UBS Financial Services Inc, as attorney-in-fact for Linda Rebrovick
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)